PrognosDx Health Announces Appointments of Dr. Garry Nolan to Board of Directors and Dr. Joseph Presti to Scientific Advisory Board

PALO ALTO, Calif.--(BUSINESS WIRE)--PrognosDx Health, Inc., an epigenetics pioneer harnessing the predictive power of global patterns of histone modifications, announced today the appointment of Garry P. Nolan, Ph.D. as Vice Chairman.

MORE ON THIS TOPIC